The 4000th eye tumour patient treated with protons at HZB

Overview: Number of patients treated with prontons at HZB from 1998 to 2020.  

Overview: Number of patients treated with prontons at HZB from 1998 to 2020.   © HZB/S. Kodalle

On 19 February 2021, the 4000th eye tumour patient received irradiation with protons, performed by a joint team from Helmholtz-Zentrum Berlin (HZB) and Charité - Universitätsmedizin Berlin. The number of patients treated in 2020 remained at the previous year's level despite the more difficult corona conditions. The treatment in Berlin-Wannsee is only available for uveal melanomas of the eye. The proton accelerator at HZB is the only therapy site for this disease in Germany.

For more than 20 years, Charité - Universitätsmedizin Berlin and Helmholtz-Zentrum Berlin (HZB) have jointly offered irradiation of eye tumours with protons. For this purpose, the HZB operates a proton accelerator, while the medical care of patients is provided by the Charité.

"We congratulate the joint team on this great success and thank them for doing everything they could under the difficult pandemic conditions to maintain the operation of the life-saving eye tumour therapy," says Prof. Bernd Rech, spokesman for the scientific management of HZB. 

500 to 600 people contract malignant uveal melanoma in Germany every year. In 97 percent of cases, the tumour can be completely destroyed by irradiation with protons. In most cases, not only the eye but also the vision can be preserved to a satisfactory degree. Radiation with protons is a particularly effective method: the energy of the proton beam can be adjusted in such a way that practically only the tumour receives the radiation, while the surrounding healthy tissue is spared.

sz

  • Copy link

You might also be interested in

  • Industrial Research Fellow at HZB: More time for discussions
    Interview
    12.05.2025
    Industrial Research Fellow at HZB: More time for discussions
    The South African chemist Denzil Moodley is the first Industrial Research Fellow at HZB. He is playing a leading role in the CARE-O-SENE project. The Fellowship program aims to further accelerate the development of an efficient catalyst for a sustainable aviation fuel. An interview about the CARE-O-SENE project and why it is so important for scientists from industry and public research to work together.
  • Perovskites: Hybrid materials as highly sensitive X-ray detectors
    Science Highlight
    08.05.2025
    Perovskites: Hybrid materials as highly sensitive X-ray detectors
    New bismuth-based organic-inorganic hybrid materials show exceptional sensitivity and long-term stability as X-ray detectors, significantly more sensitive than commercial X-ray detectors. In addition, these materials can be produced without solvents by ball milling, a mechanochemical synthesis process that is environmentally friendly and scalable. More sensitive detectors would allow for a reduction in the radiation exposure during X-ray examinations.
  • Electrical energy storage: BAM, HZB, and HU Berlin plan joint Berlin Battery Lab
    News
    07.05.2025
    Electrical energy storage: BAM, HZB, and HU Berlin plan joint Berlin Battery Lab
    The Federal Institute for Materials Research and Testing (BAM), the Helmholtz-Zentrum Berlin (HZB), and Humboldt University of Berlin (HU Berlin) have signed a memorandum of understanding (MoU) to establish the Berlin Battery Lab. The lab will pool the expertise of the three institutions to advance the development of sustainable battery technologies. The joint research infrastructure will also be open to industry for pioneering projects in this field.